Adage Capital Partners
LOXO

Adage Capital Partners’s Loxo Oncology, Inc LOXO Stock Holding History

Adage Capital Partners’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-35,000
Closed -$5.98M – 785
2018
Q3 		$5.98M Sell
35,000
-30,000
-46% -$5.04M 0.01% 621
2018
Q2 		$11.3M Sell
65,000
-685,000
-91% -$103M 0.03% 536
2018
Q1 		$86.5M Sell
750,000
-793,192
-51% -$84.4M 0.2% 134
2017
Q4 		$130M Buy
1,543,192
+539,441
+54% +$45M 0.29% 88
2017
Q3 		$92.5M Sell
1,003,751
-276,249
-22% -$21.5M 0.22% 126
2017
Q2 		$103M Sell
1,280,000
-178,694
-12% -$9.9M 0.25% 106
2017
Q1 		$61.4M Buy
1,458,694
+288,694
+25% +$11.9M 0.15% 184
2016
Q4 		$37.6M Buy
1,170,000
+352,500
+43% +$9.04M 0.1% 247
2016
Q3 		$21.4M Hold
817,500
– – 0.06% 362
2016
Q2 		$18.9M Buy
817,500
+117,500
+17% +$2.93M 0.05% 373
2016
Q1 		$19.1M Buy
700,000
+200,000
+40% +$4.19M 0.05% 368
2015
Q4 		$14.2M Buy
+500,000
New +$13.4M 0.04% 453

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners's LOXO Position: Q4 2018 in Review

Adage Capital Partners sold out of Loxo Oncology, Inc (LOXO) in Q4 2018, closing a stake of 35,000 shares — an estimated $5.98M sold.

Adage Capital Partners first reported a position in LOXO in Q4 2015 and held it in 12 quarters. The position peaked at $130M in Q4 2017. 232 funds tracked by Wall St. Rank hold LOXO as of Q4 2018.

  • Adage Capital Partners reported no remaining Loxo Oncology, Inc position as of Q4 2018 after selling out during the quarter.
  • Adage Capital Partners sold 35,000 Loxo Oncology, Inc shares in Q4 2018, an estimated $5.98M.
  • Adage Capital Partners first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 12 quarters.
  • Adage Capital Partners's Loxo Oncology, Inc position peaked at $130M in Q4 2017.
  • 232 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2018.

Based on Adage Capital Partners's 13F filing for Q4 2018, filed 14 Feb 2019.